UBS Group AG - RXI PHARMACEUTICALS CORP NEW ownership

Back to all holdings Add to watchlist

RXI PHARMACEUTICALS CORP NEW's ticker is RXIIXXXX and the CUSIP is 74979C501. A total of 20 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS Group AG ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q4 2017$9,000
-55.0%
15,341
-54.1%
0.00%–
Q2 2017$20,000
+100.0%
33,389
+170.6%
0.00%–
Q1 2017$10,000
-37.5%
12,338
+39.1%
0.00%–
Q3 2016$16,000
+220.0%
8,868
+360.2%
0.00%–
Q2 2016$5,000–1,927–0.00%–
 Download
Other shareholders

There were no reported owners of RXI PHARMACEUTICALS CORP NEW in Q2 2017.

NameSharesValueWeighting ↓
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders